Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Natural epigallocatechin-3-gallocarboxylate nanoformulation loaded doxorubicin to construct a novel and low cardiotoxicity chemotherapeutic drug for high-efficiency breast cancer therapy.

  • Authors : Wang K; School of Life and Environmental Sciences, Shaoxing University, Shaoxing, 312000, Zhejiang, China.; Laboratory of Nanomedicine, Medical Science Research Center, School of Medicine, Shaoxing University, Shaoxing, 312000, Zhejiang, China.

Subjects: Doxorubicin*/Doxorubicin*/Doxorubicin*/pharmacology ; Doxorubicin*/Doxorubicin*/Doxorubicin*/chemistry ; Catechin*/Catechin*/Catechin*/analogs & derivatives

  • Source: Journal of nanobiotechnology [J Nanobiotechnology] 2024 Dec 24; Vol. 22 (1), pp. 793. Date of Electronic Publication: 2024 Dec 24.Publisher: BioMed Central Country of Publication: England NLM ID: 101152208 Publication Model: Electronic Cited Medium: Internet ISSN: 1477-3155

تفاصيل العنوان

×
Academic Journal

Exercise training partly ameliorates cardiac dysfunction in mice during doxorubicin treatment of breast cancer.

  • Authors : Uurasmaa TM; Department of Biology, University of Turku, Turku, Finland. .; Turku PET Centre, University of Turku, Turku University Hospital, Turku, Finland. .

Subjects: Doxorubicin*/Doxorubicin*/Doxorubicin*/adverse effects ; Doxorubicin*/Doxorubicin*/Doxorubicin*/pharmacology ; Physical Conditioning, Animal*

  • Source: Journal of translational medicine [J Transl Med] 2025 Jan 21; Vol. 23 (1), pp. 89. Date of Electronic Publication: 2025 Jan 21.Publisher: BioMed Central Country of Publication: England NLM ID: 101190741 Publication Model: Electronic Cited Medium: Internet ISSN: 1479-5876

تفاصيل العنوان

×
Academic Journal

Let-7b-5p sensitizes breast cancer cells to doxorubicin through Aurora Kinase B.

  • Authors : Kaya M; Istanbul Faculty of Medicine, Department of Internal Medicine, Division of Medical Genetics, Istanbul University, Capa, Fatih, Istanbul, Turkey.; Abuaisha A

Subjects: Aurora Kinase B*/Aurora Kinase B*/Aurora Kinase B*/metabolism ; Aurora Kinase B*/Aurora Kinase B*/Aurora Kinase B*/genetics ; MicroRNAs*/MicroRNAs*/MicroRNAs*/genetics

  • Source: PloS one [PLoS One] 2025 Jan 09; Vol. 20 (1), pp. e0307420. Date of Electronic Publication: 2025 Jan 09 (Print Publication: 2025).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet

تفاصيل العنوان

×
Academic Journal

The critical role and functional mechanism of microRNA-146a in doxorubicin-induced apoptosis in breast cancer cells.

  • Authors : Tutunchi S; Department of Medical Genetics, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.; Nourmohammadi P

Subjects: MicroRNAs*/MicroRNAs*/MicroRNAs*/genetics ; MicroRNAs*/MicroRNAs*/MicroRNAs*/metabolism ; Doxorubicin*/Doxorubicin*/Doxorubicin*/pharmacology

  • Source: Nucleosides, nucleotides & nucleic acids [Nucleosides Nucleotides Nucleic Acids] 2025; Vol. 44 (2), pp. 124-135. Date of Electronic Publication: 2024 Mar 26.Publisher: Taylor & Francis Country of Publication: United States NLM ID: 100892832 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

×
Academic Journal

Liposome-enabled bufalin and doxorubicin combination therapy for trastuzumab-resistant breast cancer with a focus on cancer stem cells.

  • Authors : Gao Y; Faculty of Medical and Health Sciences, School of Pharmacy, The University of Auckland, Auckland, New Zealand.; Shelling AN

Subjects: Doxorubicin*/Doxorubicin*/Doxorubicin*/pharmacology ; Doxorubicin*/Doxorubicin*/Doxorubicin*/administration & dosage ; Bufanolides*/Bufanolides*/Bufanolides*/pharmacology

  • Source: Journal of liposome research [J Liposome Res] 2024 Sep; Vol. 34 (3), pp. 489-506. Date of Electronic Publication: 2024 Jan 25.Publisher: Informa Healthcare Country of Publication: England NLM ID: 9001952 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

×
Academic Journal

Overexpression of Glyoxalase 2 in Human Breast Cancer Cells: Implications for Cell Proliferation and Doxorubicin Resistance.

  • Authors : Romaldi B; Department of Odontostomatologic and Specialized Clinical Sciences, Università Politecnica delle Marche, 60131 Ancona, Italy.; Scirè A

Subjects: Breast Neoplasms*/Breast Neoplasms*/Breast Neoplasms*/metabolism ; Breast Neoplasms*/Breast Neoplasms*/Breast Neoplasms*/drug therapy ; Breast Neoplasms*/Breast Neoplasms*/Breast Neoplasms*/pathology

  • Source: International journal of molecular sciences [Int J Mol Sci] 2024 Oct 10; Vol. 25 (20). Date of Electronic Publication: 2024 Oct 10.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067

تفاصيل العنوان

×
Academic Journal

Cytostatic Bacterial Metabolites Interfere with 5-Fluorouracil, Doxorubicin and Paclitaxel Efficiency in 4T1 Breast Cancer Cells.

  • Authors : Schwarcz S; Department of Medical Chemistry, Faculty of Medicine, University of Debrecen, 4032 Debrecen, Hungary.; Nyerges P

Subjects: Paclitaxel*/Paclitaxel*/Paclitaxel*/pharmacology ; Fluorouracil*/Fluorouracil*/Fluorouracil*/pharmacology ; Doxorubicin*/Doxorubicin*/Doxorubicin*/pharmacology

  • Source: Molecules (Basel, Switzerland) [Molecules] 2024 Jun 27; Vol. 29 (13). Date of Electronic Publication: 2024 Jun 27.Publisher: MDPI Country of Publication: Switzerland NLM ID: 100964009 Publication Model: Electronic Cited Medium: Internet ISSN: 1420-3049

تفاصيل العنوان

×
Academic Journal

Apigenin's Modulation of Doxorubicin Efficacy in Breast Cancer.

  • Authors : Golonko A; Clinical Research Centre, Medical University of Bialystok, 15-089 Bialystok, Poland.; Olichwier AJ

Subjects: Apigenin*/Apigenin*/Apigenin*/pharmacology ; Apigenin*/Apigenin*/Apigenin*/chemistry ; Doxorubicin*/Doxorubicin*/Doxorubicin*/pharmacology

  • Source: Molecules (Basel, Switzerland) [Molecules] 2024 Jun 01; Vol. 29 (11). Date of Electronic Publication: 2024 Jun 01.Publisher: MDPI Country of Publication: Switzerland NLM ID: 100964009 Publication Model: Electronic Cited Medium: Internet ISSN: 1420-3049

تفاصيل العنوان

×
Academic Journal

Baicalin and Baicalein Enhance Cytotoxicity, Proapoptotic Activity, and Genotoxicity of Doxorubicin and Docetaxel in MCF-7 Breast Cancer Cells.

  • Authors : Bernasinska-Slomczewska J; Department of Oncobiology and Epigenetics, Faculty of Biology and Environmental Protection, University of Lodz, Pomorska 141/143 Str., 90-236 Lodz, Poland.; Hikisz P

Subjects: Flavonoids*/Flavonoids*/Flavonoids*/pharmacology ; Flavanones*/Flavanones*/Flavanones*/pharmacology ; Docetaxel*/Docetaxel*/Docetaxel*/pharmacology

  • Source: Molecules (Basel, Switzerland) [Molecules] 2024 May 25; Vol. 29 (11). Date of Electronic Publication: 2024 May 25.Publisher: MDPI Country of Publication: Switzerland NLM ID: 100964009 Publication Model: Electronic Cited Medium: Internet ISSN: 1420-3049

تفاصيل العنوان

×
Academic Journal

Numerical study of doxorubicin transdermal delivery for breast cancer treatment using microneedles.

  • Authors : Barhoumi H; Biomechanics and Biomedical Engineering, IP Paris: Polytechnic Institute of Paris, Palaiseau, France.; Léonard de Vinci Pôle Universitaire, Research Center, Paris La Defense, France.

Subjects: Doxorubicin*/Doxorubicin*/Doxorubicin*/administration & dosage ; Doxorubicin*/Doxorubicin*/Doxorubicin*/pharmacokinetics ; Breast Neoplasms*/Breast Neoplasms*/Breast Neoplasms*/drug therapy

  • Source: International journal for numerical methods in biomedical engineering [Int J Numer Method Biomed Eng] 2024 May; Vol. 40 (5), pp. e3812. Date of Electronic Publication: 2024 Mar 27.Publisher: Wiley Country of Publication: England NLM ID: 101530293 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2040-7947

تفاصيل العنوان

×
  • 1-10 ل  4,403 نتائج ل ""DOXORUBICIN""